Metformin's contraindications should be contraindicated
- PMID: 16129871
- PMCID: PMC1188187
- DOI: 10.1503/cmaj.045292
Metformin's contraindications should be contraindicated
Comment in
-
Metformin's contraindications: needed for now.CMAJ. 2005 Aug 30;173(5):505-7. doi: 10.1503/cmaj.050401. CMAJ. 2005. PMID: 16129872 Free PMC article. No abstract available.
Similar articles
-
Metformin in type 2 diabetes.J Fam Pract. 2004 Nov;53(11):900. J Fam Pract. 2004. PMID: 15527727 No abstract available.
-
Metformin, heart failure, and lactic acidosis: is metformin absolutely contraindicated?BMJ. 2007 Sep 8;335(7618):508-12. doi: 10.1136/bmj.39255.669444.AE. BMJ. 2007. PMID: 17823192 Free PMC article. Review.
-
Risk factors for metformin-associated lactic acidosis.WMJ. 1999 Jul-Aug;98(4):56-7. WMJ. 1999. PMID: 10555481 No abstract available.
-
[Does a reduced kidney function (creatinine clearance 10-15 ml/min), without acidosis, increase the risk for the rise of lactic acidosis caused by metformin?].Ned Tijdschr Geneeskd. 2002 Nov 16;146(46):2213. Ned Tijdschr Geneeskd. 2002. PMID: 12583406 Dutch. No abstract available.
-
The safety of metformin in heart failure.Ann Pharmacother. 2007 Apr;41(4):642-6. doi: 10.1345/aph.1H523. Epub 2007 Mar 20. Ann Pharmacother. 2007. PMID: 17374622 Review.
Cited by
-
Assessing the incidence of acidosis in patients receiving metformin with and without risk factors for lactic acidosis.Ther Adv Chronic Dis. 2018 Jun 13;9(9):179-190. doi: 10.1177/2040622318779760. eCollection 2018 Sep. Ther Adv Chronic Dis. 2018. PMID: 30181847 Free PMC article.
-
Protective role of the antidiabetic drug metformin against chronic experimental pulmonary hypertension.Br J Pharmacol. 2009 Nov;158(5):1285-94. doi: 10.1111/j.1476-5381.2009.00445.x. Epub 2009 Oct 8. Br J Pharmacol. 2009. PMID: 19814724 Free PMC article.
-
Metformin treatment in diabetes and heart failure: when academic equipoise meets clinical reality.Trials. 2009 Feb 9;10:12. doi: 10.1186/1745-6215-10-12. Trials. 2009. PMID: 19203392 Free PMC article. Clinical Trial.
-
[Metformin and type-2 diabetes mellitus].Aten Primaria. 2008 Mar;40(3):147-53. doi: 10.1157/13116631. Aten Primaria. 2008. PMID: 18373928 Free PMC article. Review. Spanish. No abstract available.
-
Guidelines adherence in the treatment of patients with newly diagnosed type 2 diabetes: a historical cohort comparing the use of metformin in Quebec pre and post-Canadian Diabetes Association guidelines.BMC Health Serv Res. 2013 Oct 25;13:442. doi: 10.1186/1472-6963-13-442. BMC Health Serv Res. 2013. PMID: 24160916 Free PMC article.
References
-
- Howlett HCS, Bailey CJ. A risk–benefit assessment of metformin in type 2 diabetes mellitus. Drug Saf 1999;20:489-503. - PubMed
-
- UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 1998;352:854-65. - PubMed
-
- Stang M, Wysowski DK, Butler-Jones D. Incidence of lactic acidosis in metformin users. Diabetes Care 1999;22:925-7. - PubMed
-
- Canadian Pharmacists Association. Compendium of pharmaceuticals and specialties. Ottawa: The Association; 2001.
-
- Calabrese AT, Coley KC, DaPos SV, Swanson D, Rao RH. Evaluation of prescribing practices: risk of lactic acidosis with metformin therapy. Arch Intern Med 2002;162:434-7. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical